[-]Narrow by subject
There are no subject folders to display

Results 1 - 3 of 3 for nasal lamella within all areas of the EPA. Only web pages are included. Search all document formats.
Did you mean: nasal lamely ?

IRIS Summary on Acrolein (CASRN 107-02-8)01-28-2010
"This is a summary of infornation on Acrolein (CASRN 107-02-8) provided by the Integrated Risk Information System (IRIS)"
http://www.epa.gov/NCEA/iris/subst/0364.htm (HTML)
Acrolein (CASRN 107-02-8) | IRIS | US EPA01-28-2010
Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... Incidence data were not reported, but histopathological changes in the nasal cavity, lung, larynx, and trachea were graded as slightly, moderately ...
http://www.epa.gov/IRIS/subst/0364.htm (HTML)
Acrolein (CASRN 107-02-8) | IRIS | US EPA07-09-2009
Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... Incidence data were not reported, but histopathological changes in the nasal cavity, lung, larynx, and trachea were graded as slightly, moderately ...
http://www.epa.gov/ncea/iris/subst/0364.htm (HTML)

Jump to main content.